Lexaria Bioscience Corp. (LEXXW) NASDAQ

0.00

-0.0041(-77.36%)

Updated at January 13 03:34PM

Currency In USD

Valuation

Market Cap15.84M
Enterprise Value14.15M
P/E Ratio-1.33
PEG Ratio-0.31
Price/Sales Ratio20.74
Price/Book Ratio5.29
Enterprise/Revenue18.35
Enterprise/EBITDA-1.1

Fiscal Year

Fiscal YearAugust 31, 2025
Most Recent QuarterAugust 31, 2025

Profitability

Profit Margin-16.86
Operating Margin-16.83

Management Effectiveness

Return On Assets-2.85
Return On Equity-1.87

Income Statement

Revenue705,923
Revenue/Share0.04
Gross Profit703,203
EBITDA-11.88M
Net Income-11.9M
Diluted EPS-0.66

Balance Sheet

Total Cash1.97M
Total Cash/Share0.1
Total Debt109,320
Total Debt/Equity0.04
Current Ratio2.32
Book Value Per Share0.13

Price History

52-Week Change-99.8
52-Week High0.03
52-Week Low0
Moving Average 50 Days0.03
Moving Average 200 Days0.16

Statistics

Average Volume12,494.23
Shares Outstanding22.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A